Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021
Synopsis

Epidemiology, Clinical Features, and Outcomes of Coccidioidomycosis, Utah, 2006–2015

Adrienne CareyComments to Author , Morgan E. Gorris, Tom Chiller, Brendan Jackson, Wei Beadles, and Brandon J. Webb
Author affiliations: University of Utah School of Medicine, Salt Lake City, Utah, USA (A. Carey); Los Alamos National Laboratory, Los Alamos, New Mexico, USA (M. Gorris); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (T. Chiller, B. Jackson); Utah Department of Health, Salt Lake City (W. Beadles); Intermountain Healthcare, Salt Lake City (B. Webb); Stanford University School of Medicine, Palo Alto, California, USA (B. Webb)

Main Article

Table 2

Clinical features based on case classification from the Intermountain Healthcare system, Utah, USA, 2006–2015

Characteristic
 No. (%) cases
Total
 Proven
 Probable
Total 364 (100) 192 (52.7) 172 (47.3)
Primary method of diagnosis
Laboratory 189 (51.9) 17 (8.9) 172 (100)
Microbiology 43 (11.8) 43 (22.4) 0
Pathology 106 (29.1) 106 (55.2) 0
Microbiology, pathology
 26 (7.1)
 26 (13.5)
 0
Infection site
Abdomen, peritoneal fluid 1 (0.3) 1 (0.5) 0
Adrenal 2 (0.5) 2 (1.0) 0
Back 1 (0.3) 1 (0.5) 0
Disseminated 11 (3.0) 10 (5.2) 1 (0.6)
Extremity 6 (1.6) 6 (3.1) 0
Liver 1 (0.3) 0 1 (0.6)
Lung only 316 (86.8) 154 (80.2) 162 (94.2)
Lung and lymph node 7 (1.9) 7 (3.6) 0
Lymph node only 4 (1.1) 4 (2.1) 0
Meningitis 4 (1.1) 3 (1.6) 1 (0.6)
Skin 5 (1.4) 3 (1.6) 2 (1.2)
Unknown
 6 (1.6)
 1 (0.5)
 5 (2.9)
Location of diagnosis
Urgent care/emergency department 12 (3.3) 2 (1.0) 10 (5.8)
Inpatient hospital 110 (30.2) 59 (30.7) 51 (29.7)
Primary care provider 43 (11.8) 22 (11.5) 21 (12.2)
Pulmonary department 84 (23.1) 40 (20.8) 44 (25.6)
Infectious diseases 3 (0.8) 0 3 (1.7)
Surgery department 39 (10.7) 38 (19.8) 1 (0.6)
Other 24 (6.6) 19 (9.9) 5 (2.9)
Unknown 50 (13.7) 12 (6.3) 38 (22.1)
Diagnosed as work-up for malignancy 104 (28.6) 100 (52.1) 4 (2.33)

Main Article

Page created: June 09, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external